BiondVax Pharmaceuticals Ltd.

BVXV · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$14,075$54,036$2,930$72,467
Short-Term Investments$0$0$0$0
Receivables$110$306$374$349
Inventory$0$0$0$0
Other Curr. Assets$0$0$0$0
Total Curr. Assets$14,370$55,048$3,304$73,123
Property Plant & Equip (Net)$12,697$44,107$14,247$42,117
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$444$147$510
Total NC Assets$12,697$44,551$14,394$42,627
Other Assets$0$0$0$0
Total Assets$27,067$99,599$17,699$115,750
Liabilities
Payables$716$3,107$581$17,062
Short-Term Debt$382$773$18,994$694
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,240$3,327$387$1,203
Total Curr. Liab.$2,338$7,207$19,962$18,959
LT Debt$21,160$68,964$1,893$130,589
Deferred Rev, NC$0$0$0$14,812
Deferred Tax Liab, NC$0$0$0$1,631
Other NC Liab.$5,329$95$383$14,812
Total NC Liab.$26,489$69,059$2,276$161,844
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$28,827$76,266$22,238$180,803
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$115,835-$364,771-$101,007-$320,338
AOCI-$2,007$0$0$0
Other Equity$116,082$388,104$96,468$255,285
Total Equity-$1,760$23,333-$4,539-$65,053
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$27,067$99,599$17,699$115,750
Net Debt$7,467$15,701$17,957$58,816
BiondVax Pharmaceuticals Ltd. (BVXV) Financial Statements & Key Stats | AlphaPilot